Fig. 4From: mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysisForest plot showing the relative risk of graft loss (a) and death-censored graft loss (b)Back to article page